Boothbay Fund Management’s ARS Pharmaceuticals SPRY Stock Holding History

Boothbay Fund Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.32M	Buy
2023 Q2	–	Sell
2023 Q1	$99.7K	Buy
2022 Q4	$99.2K	Buy